[go: up one dir, main page]

AR026424A1 - Soluciones que contienen epinastina - Google Patents

Soluciones que contienen epinastina

Info

Publication number
AR026424A1
AR026424A1 ARP000105932A ARP000105932A AR026424A1 AR 026424 A1 AR026424 A1 AR 026424A1 AR P000105932 A ARP000105932 A AR P000105932A AR P000105932 A ARP000105932 A AR P000105932A AR 026424 A1 AR026424 A1 AR 026424A1
Authority
AR
Argentina
Prior art keywords
solutions containing
containing epinastine
possibly
epinastine
spinastine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Suspension/Interruption
Application number
ARP000105932A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026424(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR026424A1 publication Critical patent/AR026424A1/es
Suspension/Interruption legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

La presente se refiere a soluciones acuosas aplicables por vía topica que contienen espinastina, eventualmente en forma de sus racematos, sus enantiomeros,así como eventualmente en forma de sus sales por adicion de ácidos farmacologicamente inocuas.
ARP000105932A 1999-11-12 2000-11-10 Soluciones que contienen epinastina Suspension/Interruption AR026424A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen

Publications (1)

Publication Number Publication Date
AR026424A1 true AR026424A1 (es) 2003-02-12

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105932A Suspension/Interruption AR026424A1 (es) 1999-11-12 2000-11-10 Soluciones que contienen epinastina

Country Status (40)

Country Link
US (6) US20030050303A1 (es)
EP (1) EP1231920B1 (es)
JP (1) JP2003514021A (es)
KR (1) KR100758842B1 (es)
CN (1) CN1292752C (es)
AR (1) AR026424A1 (es)
AT (1) ATE353218T1 (es)
AU (2) AU784017B2 (es)
BG (1) BG65775B1 (es)
BR (1) BR0015477A (es)
CA (1) CA2391076C (es)
CO (1) CO5251448A1 (es)
CY (1) CY1106375T1 (es)
CZ (1) CZ302483B6 (es)
DE (2) DE19954516A1 (es)
DK (1) DK1231920T3 (es)
EA (1) EA006937B1 (es)
EE (1) EE05395B1 (es)
ES (1) ES2281359T3 (es)
HK (1) HK1052303B (es)
HR (1) HRP20020404B1 (es)
HU (1) HU229502B1 (es)
IL (2) IL149501A0 (es)
ME (1) MEP36708A (es)
MX (1) MXPA02004556A (es)
MY (1) MY130441A (es)
NO (1) NO329417B1 (es)
NZ (1) NZ519425A (es)
PE (1) PE20010826A1 (es)
PL (1) PL198879B1 (es)
PT (1) PT1231920E (es)
RS (1) RS50173B (es)
SA (1) SA01210658B1 (es)
SI (1) SI1231920T1 (es)
SK (1) SK287343B6 (es)
TR (1) TR200201270T2 (es)
TW (1) TWI225401B (es)
UA (1) UA74563C2 (es)
WO (1) WO2001035962A1 (es)
ZA (1) ZA200203683B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
AU2003250073A1 (en) * 2002-08-02 2004-02-25 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
EP1901724A1 (en) * 2005-07-08 2008-03-26 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
EP2934510B1 (en) * 2012-12-19 2020-10-28 Novartis AG Lfa-1 inhibitor formulations
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
JP6487609B1 (ja) * 2017-05-01 2019-03-20 参天製薬株式会社 点眼剤
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
JP7114668B2 (ja) 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US8632A (en) * 1852-01-06 George hess
US215396A (en) * 1879-05-13 Improvement in loom-temples
US181478A (en) * 1876-08-22 Improvement in water-wheels
US228359A (en) * 1880-06-01 jones
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
DE59609627D1 (de) * 1995-06-27 2002-10-10 Boehringer Ingelheim Pharma Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
JP3124041B2 (ja) * 1996-08-30 2001-01-15 京都薬品工業株式会社 アレルギー性皮膚炎治療剤
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
TR200201322T2 (tr) * 1999-11-18 2002-11-21 Alcon, Inc. H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
US7420602B2 (en) * 2001-05-29 2008-09-02 Samsung Semiconductor Israel R&D Center (Sirc) Cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
YU33602A (sh) 2005-03-15
US20030050303A1 (en) 2003-03-13
SI1231920T1 (sl) 2007-06-30
US20070197503A1 (en) 2007-08-23
KR20020050273A (ko) 2002-06-26
SA01210658B1 (ar) 2006-11-05
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
HU229502B1 (en) 2014-01-28
ATE353218T1 (de) 2007-02-15
ES2281359T3 (es) 2007-10-01
TWI225401B (en) 2004-12-21
EA200200492A1 (ru) 2002-10-31
US20090239842A1 (en) 2009-09-24
NZ519425A (en) 2004-04-30
BG106681A (en) 2002-12-29
AU1138101A (en) 2001-05-30
RS50173B (sr) 2009-05-06
HK1052303A1 (en) 2003-09-11
PL198879B1 (pl) 2008-07-31
EE05395B1 (et) 2011-04-15
BR0015477A (pt) 2002-06-25
CO5251448A1 (es) 2003-02-28
IL149501A0 (en) 2002-11-10
US7429602B2 (en) 2008-09-30
PE20010826A1 (es) 2001-08-20
EP1231920A1 (de) 2002-08-21
MEP36708A (en) 2011-02-10
HUP0203773A3 (en) 2005-01-28
US20050288274A1 (en) 2005-12-29
NO20022201L (no) 2002-05-08
PT1231920E (pt) 2007-03-30
CY1106375T1 (el) 2011-10-12
CA2391076A1 (en) 2001-05-25
UA74563C2 (uk) 2006-01-16
PL364028A1 (en) 2004-11-29
BG65775B1 (bg) 2009-11-30
SK287343B6 (sk) 2010-07-07
CZ302483B6 (cs) 2011-06-08
CZ20021956A3 (cs) 2002-08-14
CN1390129A (zh) 2003-01-08
TR200201270T2 (tr) 2002-12-23
US20070185082A1 (en) 2007-08-09
WO2001035962A1 (de) 2001-05-25
NO329417B1 (no) 2010-10-18
US20080009476A1 (en) 2008-01-10
CA2391076C (en) 2008-06-17
DE19954516A1 (de) 2001-05-17
HK1052303B (zh) 2007-04-13
AU2006201541A1 (en) 2006-05-11
EP1231920B1 (de) 2007-02-07
DE50014041D1 (de) 2007-03-22
KR100758842B1 (ko) 2007-09-19
JP2003514021A (ja) 2003-04-15
CN1292752C (zh) 2007-01-03
AU784017B2 (en) 2006-01-12
MXPA02004556A (es) 2004-09-10
IL149501A (en) 2012-04-30
ZA200203683B (en) 2003-09-03
HRP20020404B1 (en) 2007-08-31
SK8302002A3 (en) 2002-09-10
MY130441A (en) 2007-06-29
EE200200246A (et) 2003-06-16
EA006937B1 (ru) 2006-06-30
NO20022201D0 (no) 2002-05-08
DK1231920T3 (da) 2007-04-10

Similar Documents

Publication Publication Date Title
AR026424A1 (es) Soluciones que contienen epinastina
CO4520208A1 (es) Estabilizador para perforacion direccional
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
GT199900055A (es) Nuevas dihidropirimidinas2 heterocìclicamente sustituidas.
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
CR9980A (es) Imidazolinas 4,4,5,5 tetrasustituidas
UY28069A1 (es) Nuevos derivados de xantina, su preparación y su uso como medicamento
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
AR026433A1 (es) Variantes de alfa-amilasa tipo fungamyl
BR9911431A (pt) Processo para produção de uma solução aquosa de ácido monoéster peroxicarboxìlico
DE50306796D1 (de) Dermales applikationssystem für aminolävulinsäure-derivate
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0210664A (pt) Processo de sìntese técnico para produção de tropenol
UY26954A1 (es) Procedimiento para preparar 3-amino-2-cloro-4-metilpiridina
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
UY27612A1 (es) Sales estables del ácido o-acetilsalicílico con aminoácidos básicos l l
BR0016149A (pt) Processo para a preparaçao de 5-(1-piperazinil)benzofuran-2-carboxiamida por aminação catalisada por metal de transição
ECSP003758A (es) Soluciones que contienen epinastina
UY26432A1 (es) Soluciones que contienen epinastina
AR031175A1 (es) Decoloracion del guarapo por medio de intercambiadores de aniones monodispersados
AR027349A1 (es) Derivados de amidas heterociclicas
HN2000000090A (es) Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.
BRPI0512701A (pt) sais fundidos, método de sua produção e processo para geração de peróxido de hidrogênio
AR078093A1 (es) Oligosacaridos n- sulfatados activadores de los receptores de los fgf, su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure